Alembic Ltd
ALEMBICLTDAlembic Ltd
ALEMBICLTD


Price Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
8.46 | 1.22 | 2.32% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
48.67 | 6.19 | 0.55% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Alembic Limited is engaged in the business of pharmaceuticals, real estate and power assets. The Company's segments include API and Real Estate.
Peers
Compare with peersGet more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 162.76 | 178.13 | 162.32 | 153.26 | 167.33 | 83.79 | 167.40 | 191.50 | 212.26 | 284.62 | ||||||||||
Raw Materials | 37.64 | 50.97 | 39.86 | 45.21 | 24.59 | 11.77 | 8.53 | 6.92 | 8.62 | 120.12 | ||||||||||
Power & Fuel Cost | 13.26 | 5.46 | 1.11 | 2.34 | 0.91 | 0.42 | 0.15 | 2.02 | 1.18 | |||||||||||
Employee Cost | 27.01 | 28.64 | 19.64 | 20.52 | 20.79 | 22.60 | 21.47 | 24.04 | 23.03 | |||||||||||
Selling & Administrative Expenses | 7.62 | 7.38 | 7.13 | 7.26 | 9.17 | 7.56 | 9.82 | 10.81 | 14.04 | |||||||||||
Operating & Other expenses | 45.64 | 53.80 | 46.45 | 30.41 | 15.19 | 20.10 | 24.33 | 53.73 | 53.76 | |||||||||||
EBITDA | 31.59 | 31.88 | 48.13 | 47.52 | 96.68 | 21.34 | 103.10 | 93.98 | 111.63 | 164.50 | ||||||||||
Depreciation/Amortization | 6.14 | 5.09 | 3.78 | 2.63 | 3.23 | 3.94 | 4.86 | 6.72 | 7.84 | 9.35 | ||||||||||
PBIT | 25.45 | 26.79 | 44.35 | 44.89 | 93.45 | 17.40 | 98.24 | 87.26 | 103.79 | 155.15 | ||||||||||
Interest & Other Items | 0.12 | 0.16 | 0.17 | 0.22 | 0.29 | 0.36 | 0.39 | 0.47 | 1.11 | 2.33 | ||||||||||
PBT | 25.33 | 26.63 | 44.18 | 44.67 | 93.16 | 17.04 | 97.85 | 86.79 | 102.68 | 152.82 | ||||||||||
Taxes & Other Items | -209.18 | -118.75 | -118.81 | -168.43 | -235.95 | -325.80 | -124.20 | -103.85 | -165.93 | -161.56 | ||||||||||
Net Income | 234.51 | 145.38 | 162.99 | 213.10 | 329.11 | 342.84 | 222.05 | 190.64 | 268.61 | 314.38 | ||||||||||
EPS | 7.15 | 4.43 | 4.97 | 6.62 | 11.50 | 13.35 | 8.65 | 7.42 | 10.46 | 12.24 | ||||||||||
DPS | 0.12 | 0.16 | 0.16 | 0.16 | 0.60 | 0.20 | 1.80 | 2.20 | 2.40 | 2.40 | ||||||||||
Payout ratio | 0.02 | 0.04 | 0.03 | 0.02 | 0.05 | 0.01 | 0.21 | 0.30 | 0.23 | 0.20 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Alembic Ltd | 9.91 | 1.22 | 2.32% |
Sun Pharmaceutical Industries Ltd | 43.75 | 6.24 | 0.77% |
Cipla Ltd | 28.85 | 4.44 | 0.88% |
Torrent Pharmaceuticals Ltd | 62.82 | 15.18 | 0.91% |
Price Comparison
Compare ALEMBICLTD with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Dividend Yield
Current dividend yield is 2.29%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹22.93 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 5, 2024
Dividend/Share
₹2.40
Ex DateEx Date
Aug 5, 2024
Cash Dividend
Ex DateEx DateAug 3, 2023
Dividend/Share
₹2.20
Ex DateEx Date
Aug 3, 2023
Cash Dividend
Ex DateEx DateSep 12, 2022
Dividend/Share
₹1.80
Ex DateEx Date
Sep 12, 2022
Cash Dividend
Ex DateEx DateJul 29, 2021
Dividend/Share
₹0.20
Ex DateEx Date
Jul 29, 2021
Cash Dividend
Ex DateEx DateJul 29, 2020
Dividend/Share
₹0.60
Ex DateEx Date
Jul 29, 2020
Profit before tax (PBT) was at Rs 27.39 crore in Q3 FY25, up 151.75% as against Rs 10.88 crore reported in the same period a year ago. Total expense jumped 13.79% year on year to Rs 34.90 crore during the quarter. Employee benefit expense stood at Rs 6.56 crore (up 17.56% YoY), while cost of materials consumed was at Rs 1.81 crore (up 14.56% YoY) during the period under review. The company's revenue from the active pharmaceutical ingredients business was at Rs 6.25 crore (down 3.55% YoY), while the real estate business came in at Rs 51.67 crore (up 57.29% YoY) during the period under review. On a 9-month basis, the net profit surged 68.8% to Rs 120.83 crore on a 49.04% rise in revenue from operations to Rs 161.62 crore in 9M FY25 over 9M FY24. Alembic is dealing in the Active Pharmaceutical Ingredient (API) Business and Real Estate Business. Shares of Alembic fell 1.69% to Rs 110.85 on the BSE.Powered by Capital Market - Live
Net profit of Alembic rose 6.50% to Rs 65.39 crore in the quarter ended December 2024 as against Rs 61.40 crore during the previous quarter ended December 2023. Sales rose 47.30% to Rs 57.92 crore in the quarter ended December 2024 as against Rs 39.32 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales57.9239.32 47 OPM %45.5829.68 - PBDT30.0813.53 122 PBT27.3910.87 152 NP65.3961.40 6 Powered by Capital Market - Live
Alembic will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - Live
Net profit of Alembic rose 33.46% to Rs 121.02 crore in the quarter ended September 2024 as against Rs 90.68 crore during the previous quarter ended September 2023. Sales rose 63.91% to Rs 52.91 crore in the quarter ended September 2024 as against Rs 32.28 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales52.9132.28 64 OPM %37.0131.44 - PBDT84.5157.89 46 PBT81.8356.03 46 NP121.0290.68 33 Powered by Capital Market - Live
Alembic will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
Net profit of Alembic rose 25.78% to Rs 55.82 crore in the quarter ended June 2024 as against Rs 44.38 crore during the previous quarter ended June 2023. Sales rose 37.84% to Rs 50.78 crore in the quarter ended June 2024 as against Rs 36.84 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales50.7836.84 38 OPM %40.1729.53 - PBDT21.8713.38 63 PBT19.3711.55 68 NP55.8244.38 26 Powered by Capital Market - Live
Alembic’s shares dip amidst US market product recall

Housing & Urban Development Corporation Ltd leads gainers in ‘A’ group

Alembic Ltd leads gainers in ‘A’ group

This multibagger stock sets record date for 90% dividend
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 6.73%, vs industry avg of 9.04%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.07% to 0.06%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 4.74%, vs industry avg of 15.28%